In your state, you are required to confirm you wish to access this information. Please enter 'QLD' or 'WA' in the field below to continue.

No thanks

Takata airbag recall – New vehicles affected

car-open-road

Earlier this year, Japanese air bag manufacturer Takata Corp issued a recall of airbags in 53 million vehicles worldwide. 550,000 of these vehicles were in Australia and required their airbags to be replaced.

The faulty airbags resulted from the manufacturing process and allow moisture to connect with the ammonium nitrite, the chemical Takata use to inflate the airbags. The moisture causes the chemical to become unstable and blow apart the metal canister designed to contain the explosion.

Affected vehicles previously included Toyota, Honda and Nissan. The vehicles affected have recently expanded to include Volkswagen. An incident in June 2015 in the United States is the first reported event involving a side airbag in a 2015 Volkswagen. The airbag, one of Takata’s newest versions, blew apart the metal canister. The driver did not seek medical attention and it is unknown whether he was cut by the shrapnel.

Takata’s official statement indicates the company does not consider this recent event to be related to previous recalls. The incident has raised questions as to whether all airbags filled with ammonium nitrate should be recalled.

 

Click to read about Product Liability claims

Written by Shine Lawyers on . Last modified: September 21, 2017.

Join the discussion

Share this article:

There are 0 comments. Be the first!

Faulty High-tech braking systems: Subaru and Honda Recalls

The safety of cars with automatic braking systems have been called into question with car manufactures issuing worldwide recalls in response to faulty program software. Car manufactures Subaru and Honda have announced large recalls due to malfunctioning technology designed to prevent rear-end crashes and avoid hitting pedestrians, yet instead are putting the vehicles at risk […]

Read more

China-Australia Free Trade Agreement: potential commercial implications

The China-Australia Free Trade Agreement (ChAFTA) was signed on the 17th June 2015, implementing a foundation in the next phase of inter-economic relationships between Australia and China. The potential for the ChAFTA to create opportunities for Australia is evident, with China accounting for Australia’s largest export market for goods and services and a nearly a […]

Read more

Breast implant suspended from Australian market

The Therapeutic Goods Association (TGA) has imposed a 6 month suspension on Cereform silicone gel-filled breast implants and associated sizers from the Australian Register of Therapeutic Goods. Since 2009, about 4800 of the implants were sold in Australia. The action taken by the TGA will now prevent the devices from being supplied to the Australian […]

Read more

Blood thinner Xarelto linked to potentially fatal bleeding

Clinical trials and post-market experience have linked widely used blood-thinning drug Xarelto and similar anticoagulants to incidences of major bleeding, some of which have been fatal. Xarelto works to reduce the tendency of blood to form clots and may be prescribed to prevent or treat blood clots in the brain, lungs, legs, or veins. Patients […]

Read more

Call Us Now

Our friendly consultants are available to talk Monday to Friday, 8:15am to 6:00pm AEST.

1800 618 851

Live Chat

Chat with Shine Lawyers through the livechat system without leaving your computer. No downloading, completely private and best of all - its easy to use.

Start a live chat now

Enquire Now

Enquire now